| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $71K | — |
| SG&A Expense | $261K | +7.0% |
| Operating Income | -$798K | +13.3% |
| Interest Expense | $301K | +430.4% |
| Income Tax | $0 | — |
| Net Income | -$8.4M | -440.2% |
| EPS (Diluted) | -$0.01 | — |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $0 | -100.0% |
| Current Assets | $12K | -96.2% |
| Total Assets | $76K | -79.6% |
| Total Liabilities | $11.1M | +199.3% |
| Stockholders' Equity | -$11.0M | -230.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$196K | -3.8% |
| Financing Cash Flow | $203K | +5.0% |